Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Great Neck, New York
mi
from
Great Neck, NY
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Great Neck, New York
mi
from
Great Neck, NY
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Houston, Texas
mi
from
Houston, TX
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Houston, Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Bologna, Italy
mi
from
Bologna,
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Bologna, Italy
mi
from
Bologna,
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Arizonia
mi
from
Mesa, AZ
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Arizonia
mi
from
Mesa, AZ
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Missouri
mi
from
Saint Louis, MO
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Missouri
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in North Carolina
mi
from
Asheville, NC
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in North Carolina
mi
from
Asheville, NC
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Ohio
mi
from
Mentor, OH
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Ohio
mi
from
Mentor, OH
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Virginia
mi
from
Chesapeake, VA
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Virginia
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Florida
mi
from
Palm Harbor, FL
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Florida
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Mission Hills, California
mi
from
Mission Hills, CA
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Mission Hills, California
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Oxnard, California
mi
from
Oxnard, CA
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Oxnard, California
mi
from
Oxnard, CA
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Great Neck, New York
mi
from
Great Neck, NY
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Great Neck, New York
mi
from
Great Neck, NY
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Greenville, South Carolina
mi
from
Greenville, SC
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Greenville, South Carolina
mi
from
Greenville, SC
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Houston, Texas
mi
from
Houston, TX
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Houston, Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Bologna, Italy
mi
from
Bologna,
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Bologna, Italy
mi
from
Bologna,
Click here to add this to my saved trials
SIBO, Immune Activation, and FGIDs in Children
Relationship Between Small Intestinal Bacterial Overgrowth (SIBO) and Immune System Activation in Childhood Abdominal Pain-Related Functional Gastrointestinal Disorders (FGIDs)
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
SIBO, Immune Activation, and FGIDs in Children
Relationship Between Small Intestinal Bacterial Overgrowth (SIBO) and Immune System Activation in Childhood Abdominal Pain-Related Functional Gastrointestinal Disorders (FGIDs)
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Utility of Bowel Ultrasound in Diagnosing Necrotizing Eneterocolitis in Congenital Heart Disease
Pilot Randomized Control Trial of Necrotizing Enterocolitis Screening Using Abdominal Radiograph Versus Bowel Ultrasound Plus Abdominal Radiograph in Congenital Heart Disease Patients
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Utility of Bowel Ultrasound in Diagnosing Necrotizing Eneterocolitis in Congenital Heart Disease
Pilot Randomized Control Trial of Necrotizing Enterocolitis Screening Using Abdominal Radiograph Versus Bowel Ultrasound Plus Abdominal Radiograph in Congenital Heart Disease Patients
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Inland Empire Liver Foundation
mi
from
Rialto, CA
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Inland Empire Liver Foundation
mi
from
Rialto, CA
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Crescent Clinical Research Center
mi
from
Metairie, LA
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Crescent Clinical Research Center
mi
from
Metairie, LA
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Concorde Medical Group
mi
from
New York, NY
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Concorde Medical Group
mi
from
New York, NY
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Gastro One
mi
from
Germantown, TN
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Gastro One
mi
from
Germantown, TN
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Quality Medical Research Pllc
mi
from
Nashville, TN
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Quality Medical Research Pllc
mi
from
Nashville, TN
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Texas Clinical Research Institute
mi
from
Arlington, TX
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Texas Clinical Research Institute
mi
from
Arlington, TX
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Texas Digestive Disease Consultants
mi
from
Dallas, TX
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Texas Digestive Disease Consultants
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
University of Calgary
mi
from
Calgary,
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
University of Calgary
mi
from
Calgary,
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Ruane Clinical Research Group
mi
from
Los Angeles, CA
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Ruane Clinical Research Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Clinical Research of South Florida
mi
from
Coral Gables, FL
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research of South Florida
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Northwestern Memorial Hospital; Clinical Research Unit
mi
from
Chicago, IL
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Northwestern Memorial Hospital; Clinical Research Unit
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Tulane University Health Sciences Center
mi
from
New Orleans, LA
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Tulane University Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Kansas City Research Institute
mi
from
Kansas City, MO
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Kansas City Research Institute
mi
from
Kansas City, MO
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Duke University Medical Center - Duke South Clinics
mi
from
Durham, NC
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Duke University Medical Center - Duke South Clinics
mi
from
Durham, NC
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Carolinas Center for Liver Disease/Carolinas HealthCare System
mi
from
Durham, NC
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Carolinas Center for Liver Disease/Carolinas HealthCare System
mi
from
Durham, NC
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
The Liver Institute at Methodist Dallas Medical Center
mi
from
Dallas, TX
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
The Liver Institute at Methodist Dallas Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Pinnacle Clinical Research
mi
from
Live Oak, TX
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Pinnacle Clinical Research
mi
from
Live Oak, TX
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
American Research Corporation at Texas Liver Institute
mi
from
San Antonio, TX
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
American Research Corporation at Texas Liver Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Intermountain Liver Disease and Transplant Center
mi
from
Murray, UT
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Intermountain Liver Disease and Transplant Center
mi
from
Murray, UT
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Bon Secours St. Mary's Hospital of Richmond, Inc. d/b/a Bon Secours Liver Institute of Virginia
mi
from
Newport News, VA
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Bon Secours St. Mary's Hospital of Richmond, Inc. d/b/a Bon Secours Liver Institute of Virginia
mi
from
Newport News, VA
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Bon Secours St. Mary's Hospital of Richmond, Inc. d/b/a Bon Secours Liver Institute of Virginia
mi
from
Richmond, VA
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Bon Secours St. Mary's Hospital of Richmond, Inc. d/b/a Bon Secours Liver Institute of Virginia
mi
from
Richmond, VA
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Mcguire Va Medical Center
mi
from
Richmond, VA
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Mcguire Va Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Swedish Organ Transplant and Liver Center
mi
from
Seattle, WA
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Swedish Organ Transplant and Liver Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Riociguat in Scleroderma Associated Digital Ulcers
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Riociguat in Scleroderma Associated Digital Ulcers
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Riociguat in Scleroderma Associated Digital Ulcers
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
Status: Enrolling
Updated:  12/31/1969
Hospital for Special Surgery (HSS)
mi
from
New York, NY
Riociguat in Scleroderma Associated Digital Ulcers
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
Status: Enrolling
Updated: 12/31/1969
Hospital for Special Surgery (HSS)
mi
from
New York, NY
Click here to add this to my saved trials
Riociguat in Scleroderma Associated Digital Ulcers
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Riociguat in Scleroderma Associated Digital Ulcers
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Riociguat in Scleroderma Associated Digital Ulcers
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Riociguat in Scleroderma Associated Digital Ulcers
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Riociguat in Scleroderma Associated Digital Ulcers
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
Status: Enrolling
Updated:  12/31/1969
Georgetown University
mi
from
Washington,
Riociguat in Scleroderma Associated Digital Ulcers
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
Status: Enrolling
Updated: 12/31/1969
Georgetown University
mi
from
Washington,
Click here to add this to my saved trials